This podcast episode discusses the potential benefits of using psilocybin and ibogaine in therapy, particularly for individuals with life-threatening illnesses and drug addiction. Phase two and three trials of psilocybin-assisted therapy include a 12-month follow-up to evaluate its long-term effects.